HOMEVULNERABILITIESCVE-2020-6572
HIGHCISA KEVIN THE WILD

CVE-2020-6572

Published: January 10, 2022

EPSS:19.07%probability of exploitation in 30 daysPercentile:95.2th

Official Description

Google Chrome Media contains a use-after-free vulnerability that allows a remote attacker to execute code via a crafted HTML page.

NVD Source

CISA KEV Advisory

Google Chrome Media Use-After-Free Vulnerability

Google Chrome Media contains a use-after-free vulnerability that allows a remote attacker to execute code via a crafted HTML page.

Added to KEV: 2022-01-10Federal patch deadline: 2022-07-10
Required Action (CISA)

Apply updates per vendor instructions.

Technical Analysis

CVE-2020-6572 requires local access, meaning attackers must already have a foothold on the target system.

Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.

CISA has added CVE-2020-6572 to the Known Exploited Vulnerabilities (KEV) catalog, confirming active exploitation in the wild. U.S. federal agencies are required to patch this within the mandated timeframe, and all organizations should treat remediation as urgent.

Affected Vendors & Products

Mentioned vendors (from description):
Google
CPE data not yet available in NVD for this CVE.

Exploit & PoC Resources

ACTIVE EXPLOITATIONConfirmed exploitation in the wild
External links open in a new tab. Always verify in a controlled environment before use.

All References (1)

Quick Facts

CVE IDCVE-2020-6572
SeverityHIGH
CISA KEVYES — Active Exploitation
ExploitIN THE WILD
EPSS (30d)19.07%
PublishedJan 10, 2022

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2020-6572 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
  • !CISA KEV: Federal agencies must patch per BOD 22-01 timeline
  • !Active exploitation confirmed — treat as P1
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.